Bionutrics, Inc.
Agreement signed to purchase Kirk Pharmaceuticals
Published in Pharma Investments, Ventures and Law Weekly, August 28th, 2005
Under the terms of the agreement, Bionutrics will purchase 100% of Kirk for $12 million in a combination of cash and debt.
Ronald H. Lane, PhD, Bionutrics' chairman and CEO stated, "This acquisition is an important step in the commercialization of Bionutrics' drug technology and further execution of our business plan. Kirk has relationships with some of the world's largest drug retailers and generic pharmaceutical companies and a growing manufacturing presence in the industry.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- 454 Life Sciences
Life science instrumentation maker gets $11.5M in milestones - Abbott Laboratories
Pharma firm reaches agreement with Brazilian government for AIDS drug - Abgenix, Inc.
Pharmaceutical firm reports loss of $0.94 per share - Able Laboratories, Inc.
Pharmaceutical firm files for Chapter 11 reorganization - Adams Respiratory Therapeutics, Inc.
Pharmaceutical firm announces underwriter exercises option - Adams Respiratory Therapeutics, Inc.
Pharmaceutical firm sets price for public offering - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
